BridgeMD
New treatment option for Cholelithiasis
Official title Pain Diary Use After Laparoscopic Cholecystectomy
ClinicalTrials.gov ID: NCT07308730
What this study is testing
- What it's testing
- This randomized controlled study aims to evaluate the effectiveness of using a pain diary in the assessment of early postoperative pain in patients undergoing laparoscopic cholecystectomy. Patients will be randomly assigned to a pain diary group or a control group receiving routine pain assessment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Admitted for elective laparoscopic cholecystectomy
- Scheduled for first-time laparoscopic cholecystectomy
- Aged 18 years or older
- Able to speak, read, and understand Turkish
- Literate
You likely can't join if
- Prolonged stay in the recovery unit due to extended effects of general anesthesia
- Admission to intensive care unit postoperatively
- Having chronic pain and receiving treatment for it
- Being a cancer patient
- Having a writing disability
- Inability to communicate
See the full eligibility criteria
- Admitted for elective laparoscopic cholecystectomy
- Scheduled for first-time laparoscopic cholecystectomy
- Aged 18 years or older
- Able to speak, read, and understand Turkish
- Literate
- Communicative and cooperative
- ASA score of 1, 2, or 3
- Expected to stay at least 24 hours in the hospital post-surgery
- Capable of understanding study instructions
- Willing to participate voluntarily
- Prolonged stay in the recovery unit due to extended effects of general anesthesia
- Admission to intensive care unit postoperatively
- Having chronic pain and receiving treatment for it
- Being a cancer patient
- Having a writing disability
- Inability to communicate
- Having cognitive, affective, verbal, visual, or auditory impairments
- Diagnosed psychiatric disorders such as anxiety or depression and using related medications
- Choosing to withdraw from the study after giving consent
The study team makes the final eligibility decision.
Where it's taking place
- Muğla, Menteşe, Turkey (Türkiye)
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Muğla, Menteşe, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.